New cost-effectiveness evidence on nirmatrelvir/ritonavir in the progression of COVID-19
Not only can SARS-CoV-2 infection result in immediate respiratory symptoms, but it can also lead to post-acute COVID-19 syndrome (PACS), lasting several months after recovery. At this year’s ISPOR in Copenhagen, Quantify Research’s own Martina Aldvén and […]